• AAPL 193.42
  • TSLA 238.72
  • AMZN 146.88
  • BTC-USD 43540.4766
  • ETH-USD 2266.8164
  • EURUSD 1.0785
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. US /
  3. GSKKF.US

Goldseek Resources Inc (GSKKF PINK) stock market data APIs

$0.3 0(0%) as of December 5, 2023

Goldseek Resources Inc Financial Data Overview

0.3
0.3
-
0.3
0.3
0.011-0.3542
19 893 K
60 283 K
0
-0.0047
0
0.982
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'GSKKF',
Type: 'Common Stock',
Name: 'Goldseek Resources Inc',
Exchange: 'PINK',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: NULL,
ISIN: NULL,
CUSIP: NULL,
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'June',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Basic Materials',
Industry: 'Gold',
GicSector: NULL,
GicGroup: NULL,
GicIndustry: NULL,
GicSubIndustry: NULL,
HomeCategory: NULL,
IsDelisted: false,
}

Goldseek Resources Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA -102 647
  • Earnings Per Share -0.01
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $49.99 See full price
Get sample
of Fundamental API Data

Get Goldseek Resources Inc Earnings via APIs

  • Latest Release 2023-06-30
  • EPS/Forecast NaN

Get Goldseek Resources Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Goldseek Resources Inc latest news via APIs

Zantac lawsuit drop ‘not as significant as it appears’ for GSK stock, analysts say

The withdrawal of a plaintiff in GSK's first Zantac lawsuit but may not be “as significant as it appears”, say analysts from RBC Europe.
  • ANALYSTS
  • RBC CAPITAL MARKETS
  • VOLUNTARY DISMISSAL

Sanofi upped to hold at Deutsche Bank as Zantac fears make a sell 'egregious'

Sanofi was upgraded to hold from sell at Deutsche Bank, after the heavy selling over the previous two days on worries about Zantac heartburn medication litigation. The first trial is set to begin on A...
  • DEUTSCHE BANK
  • EMMANUEL PAPADAKIS
  • HEARTBURN MEDICATION
  • MARKET PULSE
  • SANOFI
  • ZANTAC
Still have any questions?

Or need any other data for equities, funds or ETFs? Send us an email.

support@eodhistoricaldata.com